Panacea Index Logo

Command Palette

Search for a command to run...

Development of a mindfulness-based treatment for smoking cessation and the modification of alcohol use: A protocol for a randomized controlled trial and pilot study findings.

Contemporary clinical trials
January 1, 2021
Mikaela Hemenway et al. (8 authors)
Clinical Trial ProtocolJournal ArticleResearch Support, N.I.H., ExtramuralHuman StudyClinical
Study Details

Study Goal

The researchers aimed to develop and evaluate a mindfulness-based relapse prevention intervention (MBRP-SA) for concurrent smoking cessation and alcohol use modification.

Results Summary

Phase 1 pilot results indicated participants intended to apply mindfulness skills to address smoking and alcohol goals, leading to protocol adjustments for Phase 2, which will assess feasibility and acceptability of online MBRP-SA delivery.

Population

Individuals seeking smoking cessation and alcohol use modification (Phase 1 pilot: N=21).

Effective Dosage

Eight weekly group-based treatment sessions.

Duration

8 weeks

Interactions

None mentioned

Extracted Claims (3)
InterventionDirectionEndpointPopulationDosageImpactClaim #
mindfulness-based relapse prevention for smoking cessation and alcohol modification (MBRP-SA)
neutral
their everyday activities
Phase 1 pilot study participants (N = 21 enrolled)
-
participants planned to use the skills learned
#1
mindfulness-based relapse prevention for smoking cessation and alcohol modification (MBRP-SA)
neutral
their smoking and alcohol goals
Phase 1 pilot study participants (N = 21 enrolled)
-
participants planned to use the skills learned
#2
mindfulness-based relapse prevention for smoking cessation and alcohol modification (MBRP-SA)
neutral
as a primary treatment option for smoking cessation and alcohol use modification
-
-
will assess the feasibility and acceptability
#3
Abstract

The combined use of cigarettes and alcohol is associated with an increased risk of morbidity and mortality. Yet, efficacious interventions that address both behaviors concurrently are lacking. Smoking cessation and alcohol modification not only garner health benefits, but there is also value in addressing alcohol use in the context of smoking cessation to reduce the risk for smoking relapse. In this paper we describe the development of mindfulness-based relapse prevention for smoking cessation and alcohol modification (MBRP-SA) and pilot study findings (Phase 1). Next, details regarding the methods and design of an ongoing, randomized controlled trial, Project RISE (Phase 2), are described. MBRP-SA is a group-based intervention that consists of eight weekly treatment sessions. Results from the Phase 1 pilot study (N = 21 enrolled) indicated that participants planned to use the skills learned in their everyday activities and to address their smoking and alcohol goals. Based on the progression of Phase 1 cohorts, modifications were made to the inclusion/exclusion criteria and recruitment methods that will be implemented in Phase 2. Phase 2 will assess the feasibility and acceptability of MBRP-SA, delivered via live online groups, as a primary treatment option for smoking cessation and alcohol use modification.

Medical Subject Headings (MeSH)
HumansMindfulnessPilot ProjectsRandomized Controlled Trials as TopicSmokingSmoking CessationTobacco Smoking
Study Links
Quality Scores
SafetyNot Assessed
Efficacy65/10
Quality75/10
Citation Metrics
Total Citations7
Citations/Year1.8
Relative Citation Ratio1.01
NIH Percentile50.7%
Research Impact Scores
APT Score0.50
Weight Score2.31
Normalized Score0.61
Related Supplements
Development of a mindfulness-based treatment for smoking ces... | Panacea Index